Ischemic Cardiomyopathy develops when the heart muscle is repeatedly or severely deprived of oxygen-rich blood, most commonly because of narrowed or blocked coronary arteries. Previous heart attacks may also damage and scar areas of the heart muscle. Over time, this damage can weaken the left ventricle and reduce its ability to pump blood effectively.
The severity varies between individuals. Some patients may have reduced heart function with few symptoms, while others can develop heart failure, abnormal heart rhythms, or other cardiovascular complications.
Timely evaluation can help determine the extent of coronary artery disease, assess heart function, identify damaged or viable heart muscle, and guide appropriate treatment. Management may help relieve symptoms, reduce the risk of heart failure and dangerous arrhythmias, and improve long-term cardiovascular outcomes in selected patients. Early assessment is particularly important when symptoms such as worsening breathlessness, chest discomfort, fainting, rapid weight gain, or swelling develop.
Causes
Risk Factors
Implantable Cardioverter-Defibrillator (ICD) : Ischemic cardiomyopathy leaves behind myocardial scar tissue, placing patients at high risk for sudden cardiac death via ventricular fibrillation. An ICD is a standard primary or secondary prevention measure.
Cost Start From 11000Explore Options
Cardiac Resynchronisation Therapy (CRT) : For patients with a low ejection fraction and a wide QRS complex (such as a left bundle branch block), a biventricular pacemaker (CRT) restores synchronous ventricular beating.
Cost Start From 12000Explore Options
Left ventricular assist device (LVAD) : A mechanical pump surgically placed in the chest to help the main pumping chamber of the heart circulate blood to the body.
Cost Start From 36000Explore Options
Heart Transplant : The gold-standard replacement of a failing heart with a healthy donor heart.
Cost Start From 46000Explore Options
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Ischemic Cardiomyopathy patients in India. These services include:









Gurgaon, India
Artemis Hospital, established in 2007 in Gurgaon, India, is a 750+ bed, state-of-the-art multi-speciality hospital and the first in Gurgaon accredited by JCI and NABH. A flagship of the Apollo Tyres Group, it offers advanced care across cardiology, oncology, orthopaedics, neurology, and transplant medicine, supported by modern infrastructure and 60+ world-class operating theatres. Its Centres of Excellence span critical areas like heart, cancer, neurosciences, orthopaedics, and women & child care. Guided by values of Service, Compassion, and Integrity, Artemis combines innovation, technology, and affordability, making it a trusted international healthcare destination for comprehensive and compassionate patient care.

Mumbai, India
Sterling Wockhardt Hospital located in Mumbai, India is accredited by NABH. Also listed below are some of the most prominent infrastructural details:

Hyderabad, India
Star Hospitals located in Hyderabad, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome